Seegene Announces Q3 2021 Earnings, Continuing COVID-Era Momentum
Q3 Revenue held steady at KRW 305.3 billion Operating profit dipped slight due t o powerful investment in R&D Scheduled to introduce new diagnostic tests capable of screening 22 targets, including 3 genes of COVID-19 and 19 respiratory viruses in